Sector dividends Processa Pharmaceuticals, Inc.
Stocks
PCSA
US74275C4033
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:30:00 2026-09-15 EDT
|
5-day change | 1st Jan Change | ||
| 1.957 USD | +4.08% |
|
-9.41% | -32.06% |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 5.47M | ||
| 1.44% | 1.58% | 20.63x | 4.87x | 7.28x | 14.62x | 16.26x | 69.18B | ||
| 0.04% | 0.08% | 32.28x | 6.4x | 9.34x | 45.05x | 29.57x | 62B | ||
| -.--% | -.--% | -76.7x | 38.38x | 14.8x | -71.37x | -85.9x | 26.19B | ||
| -.--% | -.--% | 29.77x | 3.12x | 6.32x | 16.41x | 19.68x | 25.75B | ||
| -.--% | -.--% | -15.03x | 1.23x | 5.62x | -7.06x | -5.57x | 24.29B | ||
| -.--% | -.--% | 26.45x | 3.15x | 5.03x | 16.73x | 18.75x | 19.84B | ||
| 0.34% | 0.2% | 44.88x | 11.17x | 16.47x | 33.42x | 36.09x | 15.65B | ||
| -.--% | -.--% | -15.8x | 54.01x | 3569.89x | -18.25x | -15.68x | 13.88B | ||
| -.--% | -.--% | 1267.62x | 16.98x | 36.68x | 797.93x | -237.35x | 14.09B | ||
| -.--% | -.--% | 17.36x | 5.35x | 5.16x | 12.06x | 12.78x | 14.1B | ||
| -.--% | -.--% | -85.53x | 27.79x | 7.83x | -64.86x | -63.49x | 12.09B | ||
| -.--% | -.--% | -22.16x | 29.26x | 22.9x | -24.91x | -22.13x | 9.98B | ||
| -.--% | 0.01% | -414.37x | 8.42x | 15.29x | 950.13x | -320.68x | 11.18B | ||
| -.--% | -.--% | -11.83x | -75.95x | 59.49x | -12.41x | -12.18x | 9.64B | ||
| -.--% | -.--% | -7.11x | - | - | -7.36x | -6.81x | 8.81B | ||
| -.--% | -.--% | 8.29x | 4.59x | 6.95x | 11.29x | 11.67x | 8.08B | ||
| -.--% | -.--% | -31.03x | 8.16x | - | -27.3x | -28.18x | 8.02B | ||
| Average | 0.11% | 0.11% | 45.16x | 9.18x | 252.61x | 97.89x | -38.42x | 19.6B | |
| Weighted average by Cap. | 0.3% | 0.33% | 41.63x | 9.43x | 158.94x | 66.56x | -17.71x |
- Stock Market
- Stocks
- PCSA Stock
- Sector Processa Pharmaceuticals, Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















